NCT03802552View on ClinicalTrials.gov

Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2021

Conditions
OsteomyelitisSeptic ArthritisPyomyositis
Interventions
DRUG

Cefadroxil

oral one-time dose of cefadroxil

DRUG

Cephalexin

oral one-time dose of cephalexin

Trial Locations (1)

80045

Children's Hospital Colorado, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT03802552 - Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections | Biotech Hunter | Biotech Hunter